Table 2.
Comparison of quality indicators of end-of-life cancer care in the last month
| Variables | Total | Non-H group | Short-H group | Long-H group | p-value | p-value for trend test |
|---|---|---|---|---|---|---|
| N (%) | 3092(100 %) | 2630(85.1 %) | 325(10.5 %) | 137(4.4 %) | ||
| ICU admission | 580(18.8 %) | 548(20.8 %) | 22(6.8 %) | 10(7.3 %) | <0.001 | <0.001 |
| CPR | 613(19.8 %) | 595(22.6 %) | 9(2.8 %) | 9(6.6 %) | <0.001 | <0.001 |
| More than one ER visit | 153(4.9 %) | 120(4.6 %) | 29(8.9 %) | 4(2.9 %) | 0.003 | 0.217 |
| More than one admission(>1) | 695(22.5 %) | 556(21.1 %) | 103(31.7 %) | 36(26.3 %) | <0.001 | <0.001 |
| Death in acute care wards | 1182(38.2 %) | 1182(44.9 %) | 0 | 0 | - | - |
| Death in hospice ward | 302(9.8 %) | 0 | 221(68.0 %) | 81(59.1 %) | - | - |
| Anti-cancer therapy | ||||||
| Chemotherapy | 61(2.0 %) | 49(1.9 %) | 9(2.8 %) | 3(2.2 %) | 0.459 | 0.406 |
| TACE | 128(4.1 %) | 117(4.4 %) | 7(2.2 %) | 4(2.9 %) | 0.117 | 0.074 |
| HAIC | 37(1.2 %) | 30(1.1 %) | 6(1.8 %) | 1(0.7 %) | 0.496 | 0.781 |
| PEI | 10(0.3 %) | 10(0.4 %) | 0 | 0 | 0.755 | 0.215 |
| RFA | 11(0.4 %) | 11(0.4 %) | 0 | 0 | 0.771 | 0.193 |
| Radiotherapy | 157(5.1 %) | 119(4.5 %) | 25(7.7 %) | 13(9.5 %) | 0.004 | 0.001 |
| Ever anti-cancer therapy | 348(11.3 %) | 288(11.0 %) | 41(12.6 %) | 19(13.9 %) | 0.362 | 0.183 |
Abbreviations: Non-H group, patients who did not receive hospice care; Long-H group, patients who received hospice care for longer than 1 month; Short-H group, patients who received hospice care for a period shorter than 1 month; ICU, intensive care unit; CPR, cardiopulmonary resuscitation; ER, emergency room; TACE, transarterial chemoembolizations; HAIC, hepatic arterial infusion chemotherapy; PEI, percutaneous ethanol injection; RFA: radiofrequency ablation